Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2014 Oct 12;21(1):151–158. doi: 10.1016/j.bbmt.2014.10.006

Figure 1.

Figure 1

Overall survival among 1 year disease-free survivors of second allogeneic transplantation for AML, ALL, JMML and MDS: (A) adult patients (age ≥18 years at second transplant), (B) children (age <18 years at second transplant)